FGF9, belonging to the FGF family, its aberrant expression has been identified in diverse tumors, such as breast, prostate, endometrioid, and lung cancers, indicating its tumor biomarker role in various cancers 12, 13, 14, 15. The gene discussed is FGF9; the disease is neoplasm.